Next milestones

Ok,
so we are waiting for news on trials. Waiting, waiting.....
Question is, once the go ahead is given what will the reaction be from:
a) the market?
b) potential partners?
This is pretty critical as to my understanding and feel free to correct, this hasn't really been done a lot before. So if it doesn't kill them, i suspect we are at the front end of the curve. (And the reference to death is not being flippant, engineered t cell technology and immunocology can go pear shaped- hence the delay is likely to be due to being pretty careful about getting everything set up? )


So. we watch, we wait..and we love this. Because this is what its all about. Just like waiting on that core sample in spec mining. Are we on a jackpot of a dud.
If you've got the, cross them!